RSS-Feed abonnieren
DOI: 10.1055/s-0045-1809696
Platelet Function in Patients with Disseminated Intravascular Coagulation: Potential Markers for Improving DIC Diagnosis?

Abstract
Disseminated intravascular coagulation (DIC) is a severe complication often associated with critical illness. DIC is characterized by an uncontrolled systemic activation of the hemostatic system, leading to substantial consumption of platelets and coagulation factors. The diagnosis of DIC relies on a combination of clinical findings and laboratory results, yet DIC remains challenging to confirm, especially in early stages. This systematic review investigates the reported associations between platelet function and DIC and evaluates the potential of using platelet function markers as a supplement for DIC diagnosis. PubMed and Embase were searched for relevant literature. Human studies, which included patients with DIC and assessed platelet function using dynamic platelet function assays or soluble markers, were included. In total, 24 studies met the inclusion criteria. We found that DIC patients generally exhibit increased platelet activation in vivo, indicated by elevated plasma levels of soluble markers, while ex vivo platelet aggregation was consistently reduced compared to non-DIC patients and healthy controls; however, not all studies adjusted their results for platelet count. Soluble P-selectin was the most frequently studied plasma marker and was consistently increased in DIC patients; this was most pronounced when adjusted for platelet count. However, there was considerable heterogeneity between studies regarding both study design, patient populations, platelet function assessment, and DIC diagnosis, which complicates the comparison of findings across studies. Future studies accounting for low platelet counts in dynamic function tests are necessary to assess the role of platelet aggregation in relation to DIC.
Publikationsverlauf
Artikel online veröffentlicht:
17. Juni 2025
© 2025. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Helms J, Iba T, Connors JM. et al. How to manage coagulopathies in critically ill patients. Intensive Care Med 2023; 49 (03) 273-290
- 2 Iba T, Levi M, Thachil J, Levy JH. Disseminated intravascular coagulation: the past, present, and future considerations. Semin Thromb Hemost 2022; 48 (08) 978-987
- 3 Levi M, Scully M. How I treat disseminated intravascular coagulation. Blood 2018; 131 (08) 845-854
- 4 Baynes JW, Dominiczak MH. Medical Biochemistry. Edinburgh: Elsevier Health Sciences; 2018: 224
- 5 Yong J, Toh CH. Rethinking coagulation: from enzymatic cascade and cell-based reactions to a convergent model involving innate immune activation. Blood 2023; 142 (25) 2133-2145
- 6 Dicke C, Amirkhosravi A, Spath B. et al. Tissue factor-dependent and -independent pathways of systemic coagulation activation in acute myeloid leukemia: a single-center cohort study. Exp Hematol Oncol 2015; 4: 22
- 7 Adelborg K, Larsen JB, Hvas AM. Disseminated intravascular coagulation: epidemiology, biomarkers, and management. Br J Haematol 2021; 192 (05) 803-818
- 8 Taylor Jr FB, Toh CH, Hoots WK, Wada H, Levi M. Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86 (05) 1327-1330
- 9 Larsen JB, Aggerbeck MA, Granfeldt A, Schmidt M, Hvas AM, Adelborg K. Disseminated intravascular coagulation diagnosis: positive predictive value of the ISTH score in a Danish population. Res Pract Thromb Haemost 2021; 5 (08) e12636
- 10 Kobayashi N, Maekawa T, Takada M, Tanaka H, Gonmori H. Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan. Bibl Haematol 1983; (49) 265-275
- 11 Gando S, Iba T, Eguchi Y. et al; Japanese Association for Acute Medicine Disseminated Intravascular Coagulation (JAAM DIC) Study Group. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit Care Med 2006; 34 (03) 625-631
- 12 Laursen MA, Larsen JB, Larsen KM, Hvas AM. Platelet function in patients with septic shock. Thromb Res 2020; 185: 33-42
- 13 Fogagnolo A, Taccone FS, Campo G. et al. Impaired platelet reactivity in patients with septic shock: a proof-of-concept study. Platelets 2020; 31 (05) 652-660
- 14 Connolly-Andersen AM, Sundberg E, Ahlm C. et al. Increased thrombopoiesis and platelet activation in hantavirus-infected patients. J Infect Dis 2015; 212 (07) 1061-1069
- 15 Delabranche X, Boisramé-Helms J, Asfar P. et al. Microparticles are new biomarkers of septic shock-induced disseminated intravascular coagulopathy. Intensive Care Med 2013; 39 (10) 1695-1703
- 16 Ishikura H, Irie Y, Kawamura M. et al. Early recognition of sepsis-induced coagulopathy using the C2PAC index: a ratio of soluble type C lectin-like receptor 2 (sCLEC-2) level and platelet count. Platelets 2022; 33 (06) 935-944
- 17 Gando S, Kameue T, Matsuda N, Hayakawa M, Hoshino H, Kato H. Serial changes in neutrophil-endothelial activation markers during the course of sepsis associated with disseminated intravascular coagulation. Thromb Res 2005; 116 (02) 91-100
- 18 Brenner T, Schmidt K, Delang M. et al. Viscoelastic and aggregometric point-of-care testing in patients with septic shock—cross-links between inflammation and haemostasis. Acta Anaesthesiol Scand 2012; 56 (10) 1277-1290
- 19 Wan P, Tong HS, Zhang XQ, Duan PK, Tang YQ, Su L. Diagnosis of overt disseminated intravascular coagulation in critically Ill adults by Sonoclot coagulation analysis. Int J Hematol 2014; 100 (02) 125-131
- 20 PubMed 1966. , National Library of Medicine: Bethesda, MD. Accessed at: https://pubmed.ncbi.nlm.nih.gov
- 21 Embase. Elsevier. Accessed at: https://www.embase.com/search/quick
- 22 National Heart, Lung, and Blood Institute. Study Quality Assessment Tools. July 2021 . Accessed at: https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools
- 23 Boscolo A, Campello E, Bertini D. et al. Levels of circulating microparticles in septic shock and sepsis-related complications: a case-control study. Minerva Anestesiol 2019; 85 (06) 625-634
- 24 Folman CC, Linthorst GE, van Mourik J. et al. Platelets release thrombopoietin (Tpo) upon activation: another regulatory loop in thrombocytopoiesis?. Thromb Haemost 2000; 83 (06) 923-930
- 25 Lehner GF, Harler U, Haller VM. et al. Characterization of microvesicles in septic shock using high-sensitivity flow cytometry. Shock 2016; 46 (04) 373-381
- 26 Shimizu M, Konishi A, Nomura S. Examination of biomarker expressions in sepsis-related DIC patients. Int J Gen Med 2018; 11: 353-361
- 27 Washington AV, Gibot S, Acevedo I. et al. TREM-like transcript-1 protects against inflammation-associated hemorrhage by facilitating platelet aggregation in mice and humans. J Clin Invest 2009; 119 (06) 1489-1501
- 28 Wegrzyn G, Walborn A, Rondina M, Fareed J, Hoppensteadt D. Biomarkers of platelet activation and their prognostic value in patients with sepsis-associated disseminated intravascular coagulopathy. Clin Appl Thromb Hemost 2021; 27: 1076029620943300
- 29 Yaguchi A, Lobo FL, Vincent JL, Pradier O. Platelet function in sepsis. J Thromb Haemost 2004; 2 (12) 2096-2102
- 30 Mosad E, Elsayh KI, Eltayeb AA. Tissue factor pathway inhibitor and P-selectin as markers of sepsis-induced non-overt disseminated intravascular coagulopathy. Clin Appl Thromb Hemost 2011; 17 (01) 80-87
- 31 Kunishima S, Kobayashi S, Naoe T. Increased but highly dispersed levels of plasma glycocalicin in patients with disseminated intravascular coagulation. Eur J Haematol 1996; 56 (03) 173-177
- 32 Shimura M. et al. Increased plasma soluble-adhesion molecules in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation. Clin Appl Thromb Hemost 1998; 4 (03) 196-200
- 33 Yahara Y, Okawa S, Onozawa Y, Motomiya T, Tanoue K, Yamazaki H. Activation of platelets in cancer, especially with reference to genesis of disseminated intravascular coagulation. Thromb Res 1983; 29 (01) 27-35
- 34 Gando S, Kameue T, Matsuda N. et al. Combined activation of coagulation and inflammation has an important role in multiple organ dysfunction and poor outcome after severe trauma. Thromb Haemost 2002; 88 (06) 943-949
- 35 Chong BH, Murray B, Berndt MC, Dunlop LC, Brighton T, Chesterman CN. Plasma P-selectin is increased in thrombotic consumptive platelet disorders. Blood 1994; 83 (06) 1535-1541
- 36 Kander T, Larsson A, Taune V, Schött U, Tynngård N. Assessment of haemostasis in disseminated intravascular coagulation by use of point-of-care assays and routine coagulation tests, in critically ill patients; a prospective observational study. PLoS One 2016; 11 (03) e0151202-e0151202
- 37 Yamamoto A, Wada H, Tomida M. et al. Super formula for diagnosing disseminated intravascular coagulation using soluble C-type lectin-like receptor 2. Diagnostics (Basel) 2023; 13 (13) 2299
- 38 Ohuchi M, Fujino K, Kishimoto T. et al. Association of the plasma platelet-derived microparticles to platelet count ratio with hospital mortality and disseminated intravascular coagulopathy in critically ill patients. J Atheroscler Thromb 2015; 22 (08) 773-782
- 39 Thomas SG. 3 - The structure of resting and activated platelets. In: Michelson AD. ed Platelets. 4th ed.. Academic Press; 2019: 47-77
- 40 Moore EE, Moore HB, Kornblith LZ. et al. Trauma-induced coagulopathy. Nat Rev Dis Primers 2021; 7 (01) 30
- 41 St John AE, Newton JC, Martin EJ. et al. Platelets retain inducible alpha granule secretion by P-selectin expression but exhibit mechanical dysfunction during trauma-induced coagulopathy. J Thromb Haemost 2019; 17 (05) 771-781
- 42 Skipper MT, Rubak P, Stentoft J, Hvas AM, Larsen OH. Evaluation of platelet function in thrombocytopenia. Platelets 2018; 29 (03) 270-276
- 43 Frelinger AL. 37 - Platelet function testing in clinical research trials. In: Michelson AD. ed Platelets. 4th ed.. Academic Press; 2019: 683-700
- 44 Blair TA, Frelinger AL, Michelson AD. 35 - Flow cytometry. In: Michelson AD. ed Platelets. 4th ed.. Academic Press; 2019: 627-651
- 45 Sun L, Wang Z, Liu Z, Mu G, Cui Y, Xiang Q. C-type lectin-like receptor 2: roles and drug target. Thromb J 2024; 22 (01) 27
- 46 Meng D, Luo M, Liu B. The role of CLEC-2 and its ligands in thromboinflammation. Front Immunol 2021; 12: 688643
- 47 Jandrot-Perrus M, Busfield S, Lagrue AH. et al. Cloning, characterization, and functional studies of human and mouse glycoprotein VI: a platelet-specific collagen receptor from the immunoglobulin superfamily. Blood 2000; 96 (05) 1798-1807
- 48 Li R. 10 - The glycoprotein Ib-IX-V complex. In: Michelson AD. ed Platelets. 4th ed. Academic Press; 2019: 193-211
- 49 Debili N, Robin C, Schiavon V. et al. Different expression of CD41 on human lymphoid and myeloid progenitors from adults and neonates. Blood 2001; 97 (07) 2023-2030
- 50 Stefanidis I, Frank D, Maurin N. Hemostasis activation markers in acute renal failure. Ren Fail 1998; 20 (01) 147-155